Related references
Note: Only part of the references are listed.Overexpression of ANLN in lung adenocarcinoma is associated with metastasis
Jie Xu et al.
THORACIC CANCER (2019)
Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p
Lin-Juan Tian et al.
MEDICAL SCIENCE MONITOR (2019)
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control
Xiaofeng Dai et al.
FRONTIERS IN GENETICS (2019)
Long noncoding RNA X-inactive specific transcript promotes malignant melanoma progression and oxaliplatin resistance
Bujian Pan et al.
MELANOMA RESEARCH (2019)
PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation
Songlin Liu et al.
INVESTIGATIONAL NEW DRUGS (2018)
LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions
Cristina Barbagallo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1
Jia Zhu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Drug delivery approaches for breast cancer
Santosh Kumar Singh et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients
Zhan Wang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
High XIST and Low 53BP1 Expression Predict Poor Outcome after High-Dose Alkylating Chemotherapy in Patients with a BRCA1-like Breast Cancer
Philip C. Schouten et al.
MOLECULAR CANCER THERAPEUTICS (2016)
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
Kristina Magnusson et al.
BMC CANCER (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Cancer treatment and survivorship statistics, 2016
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival A Randomized Clinical Trial
Matteo Lambertini et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)
Haiyan Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Comparison of Protein Expression Profiles of Different Stages of Lymph Nodes Metastasis in Breast Cancer
Hui-Hua Lee et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Epigenetic Signatures in Breast Cancer: Clinical Perspective
Paola Parrella
BREAST CARE (2010)
Anthracyclines in the Treatment of Early-Stage Breast Cancer: Ally or Adversary?
Gary H. Lyman
CANCER INVESTIGATION (2010)
Targeting DNA repair in breast cancer: A clinical and translational update
Eitan Amir et al.
CANCER TREATMENT REVIEWS (2010)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
HER-2/neu and topoisomerase IIα in breast cancer
TAH Järvinen et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Share Paper
